๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ki-ras MUTATIONS IN ADENOMAS: A CHARACTERISTIC OF CANCER-BEARING COLORECTAL MUCOSA

โœ Scribed by MORRIS, ROBERT G.; CURTIS, LUCY J.; ROMANOWSKI, PIOTR; HARDCASTLE, JACK D.; JENKINS, DAVID A.; ROBINSON, MICHAEL; WYLLIE, ANDREW H.; BIRD, COLIN C.

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
652 KB
Volume
180
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.

โœฆ Synopsis

Activating mutations in the Ki-ras2 oncogene are frequently observed in sporadic colorectal adenomas and their incidence is reported to rise in large and tubulovillous adenomas to values close to those in carcinomas. This study shows that this property is a feature of adenomas growing in large bowel that has already demonstrated its propensity to engender malignant tumours: i.e., bowel in which there is a synchronous carcinoma. Adenomas from cancer-free bowel do not share this high incidence of Ki-ras mutations. This difference in mutation incidence between adenomas from cancer-free and cancer-bearing patients does not appear to derive from sampling bias relative to adenoma size, site, or patient age, nor is it found in another gene (APC) known to be of importance in adenoma formation. Large, dysplastic adenomas from cancer-bearing bowel, however, are particularly liable to carry Ki-ras mutations when they arise in patients over 70 years old. The observations suggest that the role of Ki-ras mutations may be more subtle than merely enhancing adenoma growth. Adenoma cells of cancer-prone individuals may suffer more mutational events than those in persons selected as cancer-free.

๐Ÿ“œ SIMILAR VOLUMES

Ki-ras mutations in adenomas from cancer
Ki-ras mutations in adenomas from cancer-bearing and cancer-freee bowel
โœ Zauber, N. Peter; Sabbath-Solitaire, Marlene; Bishop, D. Timothy ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 19 KB

We read with interest the paper by Morris et al. 1 reporting a higher incidence of Ki-ras oncogene mutations in villous or tubulovillous adenomas removed from cancer-bearing bowel as opposed to cancer-free bowel. Our calculation of the odds ratio for their data is 3โ€ข125. They found the higher percen

A novel high-specificity approach for co
A novel high-specificity approach for colorectal neoplasia: Detection of K-ras2 oncogene mutation in normal mucosa
โœ Shinobu Yamada; Masakazu Yashiro; Kiyoshi Maeda; Yukio Nishiguchi; Kosei Hirakaw ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 348 KB

There is an important need for a high-specificity approach to colorectal cancer. Approximately 50% of colorectal tumors contain K-ras gene mutations, which occur as an early step in carcinogenesis. K-ras mutations were detectable not only in tumors but also in microscopically normal colorectal mucos

A detailed analysis of K-ras point mutat
A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients
โœ Mary Span; Peter T. M. Moerkerk; Anton F. P. M. De Goeli; Jan Willem Arends ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 579 KB

Point mutations in codon 12, 13, and 61 of the K-ras gene are an early event in tumorigenesis of colorectal cancer, but the impact of number, type, and position of such mutations on the progression of adenomas as well as the clinical behaviour of colorectal carcinomas is not clearly established. A s

Keratin 20 is a specific marker of submi
Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations
โœ Yun, Kankatsu; Merrie, Arend E. H.; Gunn, Jeremy; Phillips, Lynn V.; McCall, Joh ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 145 KB ๐Ÿ‘ 2 views

Lymph node status has major prognostic importance in colorectal cancer and greater precision in the diagnosis of lymph node metastases should provide better prognostic and therapeutic guidance. Keratin 20 (K20) gene expression has been used as a marker of lymph node metastases, but the evidence for

Correlation between hypermethylation of
Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers
โœ Hye-Won Park; Hio Chung Kang; Il-Jin Kim; Sang-Geun Jang; Kun Kim; Hyun-Ju Yoon; ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 518 KB

## Abstract Recently, __RASSF2A__ was identified as a potential tumor suppressor epigenetically inactivated in human cancers. Here, we evaluated the methylation status of __RASSF2A__ in colorectal cancer (CRC) and analyzed its correlation with Kโ€__ras__/__BRAF__ mutations, microsatellite instabilit